Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study
Tài liệu tham khảo
Kramer, 1978, Definition of leukoplakia and related lesions: an aid to studies on oral precancer, Oral Surg. Oral Med. Oral Pathol., 46, 518, 10.1016/0030-4220(78)90383-3
Chaturvedi, 2020, Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study, J. Natl. Cancer Inst., 112, 1047, 10.1093/jnci/djz238
Chuang, 2018, Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: a prospective cohort study of Taiwanese nationwide oral cancer screening program, Oral Oncol., 87, 58, 10.1016/j.oraloncology.2018.10.021
Lodi, 2016, Interventions for treating oral leukoplakia to prevent oral cancer, Cochrane Database Syst. Rev., 7
Sundberg, 2019, Recurrence rates after surgical removal of oral leukoplakia-a prospective longitudinal multi-centre study, PLoS One, 14, 10.1371/journal.pone.0225682
Holmstrup, 2006, Long-term treatment outcome of oral premalignant lesions, Oral Oncol., 42, 461, 10.1016/j.oraloncology.2005.08.011
Dong, 2019, Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis, Lasers Med. Sci., 34, 209, 10.1007/s10103-018-2674-7
Roodenburg, 1983, Treatment of superficial lesions of the oral-mucosa with the carbon-dioxide laser: a report of 58 cases, with 5 years follow-up, J. Exp Clin. Canc. Res., 2, 283
van der Hem, 2008, CO2 laser evaporation of oral lichen planus, Int. J. Oral Maxillofac. Surg., 37, 630, 10.1016/j.ijom.2008.04.011
Lodi, 2008, Management of potentially malignant disorders: evidence and critique, J. Oral Pathol. Med., 37, 63, 10.1111/j.1600-0714.2007.00575.x
de Pauli Paglioni, 2020, Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis, Oral Oncol., 109, 10.1016/j.oraloncology.2020.104850
Roodenburg, 1991, Carbon dioxide laser surgery of oral leukoplakia, Oral Surg. Oral Med. Oral Pathol., 71, 670, 10.1016/0030-4220(91)90271-D
van der Hem, 2005, The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up, Oral Oncol., 41, 31, 10.1016/j.oraloncology.2004.06.010
Kwiatkowski, 2018, Photodynamic therapy–mechanisms, photosensitizers and combinations, Biomed. Pharmacother., 106, 1098, 10.1016/j.biopha.2018.07.049
Donohoe, 2019, Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity, Biochim. Biophys. Acta Rev. Cancer, 1872, 10.1016/j.bbcan.2019.07.003
Choi, 2017, Comparative analysis of the effects of CO2 fractional laser and sonophoresis on human skin penetration with 5-aminolevulinic acid, Lasers Med. Sci., 32, 1895, 10.1007/s10103-017-2305-8
Fan, 1996, Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity, Cancer, 78, 1374, 10.1002/(SICI)1097-0142(19961001)78:7<1374::AID-CNCR2>3.0.CO;2-L
Grant, 1993, Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity, J. Laryngol. Otol., 107, 1140, 10.1017/S0022215100125496
Huth, 2016, Ablative non-sequential fractional ultrapulsed CO2 laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model, Exp. Dermatol., 25, 997, 10.1111/exd.13068
Yao, 2020, Photodynamic therapy combined with carbon dioxide laser for low-grade vaginal intraepithelial neoplasia: A retrospective analysis, Photodiagn. Photodyn. Ther., 30, 10.1016/j.pdpdt.2020.101731
Choi, 2015, Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial, Br. J. Dermatol., 173, 184, 10.1111/bjd.13542
van der Waal, 2009, Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management, Oral Oncol., 45, 317, 10.1016/j.oraloncology.2008.05.016
Brouns, 2013, Treatment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia, Oral Dis., 19, 212, 10.1111/odi.12007
Sundberg, 2019, Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study, PLoS One, 14, 10.1371/journal.pone.0225682
Warnakulasuriya, 2016, Malignant transformation of oral leukoplakia: a systematic review of observational studies, J. Oral Pathol. Med., 45, 155, 10.1111/jop.12339
Liu, 2012, Oral cancer development in patients with leukoplakia–clinicopathological factors affecting outcome, PLoS One, 7, e34773, 10.1371/journal.pone.0034773
Liu, 2011, Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases, Histopathology, 59, 733, 10.1111/j.1365-2559.2011.03938.x
Mogedas-Vegara, 2015, The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients, J. Craniomaxillofac. Surg., 43, 677, 10.1016/j.jcms.2015.03.011
Ishii, 2004, Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features, J. Clin. Laser Med. Surg., 22, 27, 10.1089/104454704773660949
Wong, 2013, A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia, Oral Oncol., 49, 970, 10.1016/j.oraloncology.2013.05.011
Morton, 2019, European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen’s disease and basal cell carcinomas, J. Eur. Acad. Dermatol. Venereol., 33, 2225, 10.1111/jdv.16017
Peng, 2020, Targeted photodynamic therapy of human head and neck squamous cell carcinoma with anti-epidermal growth factor receptor antibody cetuximab and photosensitizer ir700dx in the mouse skin-fold window chamber model, Photochem. Photobiol., 96, 708, 10.1111/php.13267
Pietruska, 2014, Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia, Photodiagn. Photodyn. Ther., 11, 34, 10.1016/j.pdpdt.2013.10.003
Han, 2018, Primary clinical evaluation of photodynamic therapy with oral leukoplakia in Chinese patients, Front. Physiol., 9, 1911, 10.3389/fphys.2018.01911
Wong, 2019, British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018, Br. J. Dermatol., 180, 730, 10.1111/bjd.17309
Vrani, 2019, Short incubation fractional CO2 laser assisted photodynamic therapy vs. conventional photodynamic therapy in field cancerized skin: 12-month follow-up results of a randomized intraindividual comparison study, J. Eur. Acad. Dermatol. Venerol., 33, 79, 10.1111/jdv.15109
Zhang, 2017, Treatment of oral refractory large area mucosal leukoplakia with CO2 laser combined with photodynamic therapy: Case report, Photodiagn. Photodyn. Ther., 20, 193, 10.1016/j.pdpdt.2017.10.006
Yao, 2020, The combination of photodynamic therapy and fractional CO2 laser for oral leukoplakia: case series, Photodiagn. Photodyn. Ther., 29, 10.1016/j.pdpdt.2019.101597
Che, 2020, Therapeutic evaluation of 5-aminolevulinic acid-mediated photodynamic therapy in Bowenoid papulosis, Photodiagn. Photodyn. Ther., 29, 10.1016/j.pdpdt.2019.101635
Metelitsa, 2010, Fractionated laser skin resurfacing treatment complications: a review, Dermatol. Surg., 36, 299, 10.1111/j.1524-4725.2009.01434.x
Christensen, 2010, Guidelines for practical use of MAL-PDT in non-melanoma skin cancer, J. Eur. Acad. Dermatol. Venereol., 24, 505, 10.1111/j.1468-3083.2009.03430.x
